Corrigendum to "Pan-cancer analysis of MET mutation and its association with the efficacy of immune checkpoint blockade" [Genes & Dis 12 (2025) 101450]
- PMID: 40837412
- PMCID: PMC12361978
- DOI: 10.1016/j.gendis.2025.101726
Corrigendum to "Pan-cancer analysis of MET mutation and its association with the efficacy of immune checkpoint blockade" [Genes & Dis 12 (2025) 101450]
Abstract
[This corrects the article DOI: 10.1016/j.gendis.2024.101450.].
© 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Erratum for
-
Pan-cancer analysis of MET mutation and its association with the efficacy of immune checkpoint blockade.Genes Dis. 2024 Nov 8;12(4):101450. doi: 10.1016/j.gendis.2024.101450. eCollection 2025 Jul. Genes Dis. 2024. PMID: 40330151 Free PMC article.
Similar articles
-
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025. Front Immunol. 2025. PMID: 40777041 Free PMC article.
-
Pan-cancer analysis of MET mutation and its association with the efficacy of immune checkpoint blockade.Genes Dis. 2024 Nov 8;12(4):101450. doi: 10.1016/j.gendis.2024.101450. eCollection 2025 Jul. Genes Dis. 2024. PMID: 40330151 Free PMC article.
-
Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.J Cancer Res Clin Oncol. 2023 Nov;149(16):14597-14617. doi: 10.1007/s00432-023-05268-y. Epub 2023 Aug 14. J Cancer Res Clin Oncol. 2023. PMID: 37580402 Free PMC article.
-
Are immune checkpoint inhibitors safe and effective in lung cancer patients with pre-existing interstitial lung disease?Immunotherapy. 2024 Apr;16(7):465-480. doi: 10.2217/imt-2023-0147. Epub 2024 Mar 21. Immunotherapy. 2024. PMID: 38511241
-
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma.Ther Adv Med Oncol. 2025 Jul 24;17:17588359251357719. doi: 10.1177/17588359251357719. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 40727882 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous